CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 206 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05327140
NCT05327140N/ACompleted

Reliability of Inflammatory Back Pain Criteria and Activity Scores in Patients With Axial Spondyloarthritis

Zagazig University·observational·Posted Apr 14, 2022·Updated Jan 25, 2023

In Brief

An observational study for Axial Spondyloarthritis and Inflammatory Back Pain. Completed, enrolled 206 participants across 1 site.

Detailed Summary

The current ASAS classification of AxSpA relies either on sacroiliitis on imaging plus one SpA feature (imaging arm) or HLA-B27 antigen plus two SpA features (clinical arm), in a patient with chronic back pain and age at onset of less than 45 years. IBP which is a major symptom of SpA depends more on patient's perception which is not usually accurate. As well, disease activity is measured by ASDAS, BASDAI, and BASFAI which depend more on subjective measures. Assessment of reliability of IBP criteria, ASDAS, BASDAI, and BASFAI in diagnosis and evaluation of activity of AxSpA is essential for better health care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 14, 2022
Enrollment StartAug 20, 2021
Primary CompletionFeb 22, 2022
Study CompletionMay 25, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.2 years ago